BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9248957)

  • 1. What's the use of susceptibility testing?
    Greenwood D
    J Chemother; 1997 May; 9 Suppl 1():7-12. PubMed ID: 9248957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility testing: are we wasting our time?
    Greenwood D
    Br J Biomed Sci; 1993 Mar; 50(1):31-4. PubMed ID: 8032293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the microbiology laboratory in monitoring and identifying resistance: use of molecular biology.
    Pfaller MA; Cormican MG
    New Horiz; 1996 Aug; 4(3):361-9. PubMed ID: 8856754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of biocide usage and antimicrobial resistance in domiciliary environments.
    Bloomfield SF
    Symp Ser Soc Appl Microbiol; 2002; (31):144S-157S. PubMed ID: 12481839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists.
    Pakyz AL
    Pharmacotherapy; 2007 Sep; 27(9):1306-12. PubMed ID: 17723084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility testing and patterns of resistance at a tertiary care center.
    Akhter J; Qutub MO; Qadri SM
    Saudi Med J; 2001 Jul; 22(7):569-76. PubMed ID: 11479635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proposals of the working group "Antibiotic resistance" for the configuration of microtitre plates to be used in routine antimicrobial susceptibility testing of bacterial pathogens from infections of large food-producing animals and mastitis cases].
    Luhofer G; Böttner A; Hafez HM; Kaske M; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Richter A; Sigge C; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; Schwarz S;
    Berl Munch Tierarztl Wochenschr; 2004; 117(7-8):245-51. PubMed ID: 15298050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of in-vitro susceptibility testing in the management of compromised hosts.
    Venditti M; Martino P
    J Chemother; 1997 May; 9 Suppl 1():116-22. PubMed ID: 9248970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Available laboratory tests to guide antimicrobial therapy.
    Araj GF
    J Med Liban; 2000; 48(4):199-202. PubMed ID: 11214189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing pattern of neonatal bacteremia. Microbiology and antibiotic resistance.
    Ellabib MS; Ordonez A; Ramali A; Walli A; Benayad T; Shebrlo H
    Saudi Med J; 2004 Dec; 25(12):1951-6. PubMed ID: 15711674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evolution of antibiotic consumption in an intensive care burn department].
    Thabet L; Bousselmi K; Oueslati S; Memmi M; Ben Redjeb S; Messadi AA
    Tunis Med; 2007 Dec; 85(12):1035-8. PubMed ID: 19170383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential for antimicrobial resistance in Chlamydia pneumoniae.
    Stamm WE
    J Infect Dis; 2000 Jun; 181 Suppl 3():S456-9. PubMed ID: 10839739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common bacteria whose susceptibility to antimicrobials is no longer predictable.
    Snyder JW; McDonald LC; Van Enk R
    J Med Liban; 2000; 48(4):208-14. PubMed ID: 11214191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms.
    Jorgensen JH; Ferraro MJ
    Clin Infect Dis; 2000 May; 30(5):799-808. PubMed ID: 10816150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the microbiology laboratory in an era of increasing antibiotic resistance.
    Thomson KS
    Postgrad Med; 2001 Feb; 109(2 Suppl):78-81. PubMed ID: 19667561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing.
    Olsson-Liljequist B; Larsson P; Walder M; Miörner H
    Scand J Infect Dis Suppl; 1997; 105():13-23. PubMed ID: 9435027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improvement of routine works and quality control in mycobacterial laboratory].
    Suzuki K; Higuchi T
    Kekkaku; 2007 Mar; 82(3):217-27. PubMed ID: 17444126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance.
    Ringertz S; Olsson-Liljequist B; Kahlmeter G; Kronvall G
    Scand J Infect Dis Suppl; 1997; 105():8-12. PubMed ID: 9435026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Etherington C; Hall M; Conway S; Peckham D; Denton M
    J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.